Literature DB >> 31953931

Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China.

Shiyong Liu1, Tao Yu2, Yuguang Guan3, Kai Zhang4, Ping Ding5, Lei Chen6, Yongzhi Shan7, Qiang Guo8, Qingzhu Liu9, Yi Yao10, Meihua Yang1, Shaohui Zhang5, Yuanxiang Lin11, Rui Zhao12, Zhiqi Mao13, Juncheng Zhang14, Chunqing Zhang1, Rui Zhang15, Zhiquan Yang16, Ruobing Qian17, Yunlin Li18, Guangming Zhang19, Liu Yuan5, Weidong Yang20, Hong Tian21, Hua Zhang22, Wenling Li23, Xinwei Zhang24, Jian Yin25, Yanwu Guo26, Liping Zou27, Jiong Qin28, Fang Fang29, Xu Wang29, Ming Ge30, Shuli Liang31.   

Abstract

At least 50% of patients with tuberous sclerosis complex present with intractable epilepsy; for these patients, resective surgery is a treatment option. Here, we report a nationwide multicentre retrospective study and analyse the long-term seizure and neuropsychological outcomes of epilepsy surgery in patients with tuberous sclerosis complex. There were 364 patients who underwent epilepsy surgery in the study. Patients' clinical data, postoperative seizure outcomes at 1-, 4-, and 10-year follow-ups, preoperative and postoperative intelligence quotients, and quality of life at 1-year follow-up were collected. The patients' ages at surgery were 10.35 ± 7.70 years (range: 0.5-47). The percentage of postoperative seizure freedom was 71% (258/364) at 1-year, 60% (118/196) at 4-year, and 51% (36/71) at 10-year follow-up. Influence factors of postoperative seizure freedom were the total removal of epileptogenic tubers and the presence of outstanding tuber on MRI at 1- and 4-year follow-ups. Furthermore, monthly seizure (versus daily seizure) was also a positive influence factor for postoperative seizure freedom at 1-year follow-up. The presence of an outstanding tuber on MRI was the only factor influencing seizure freedom at 10-year follow-up. Postoperative quality of life and intelligence quotient improvements were found in 43% (112/262) and 28% (67/242) of patients, respectively. Influence factors of postoperative quality of life and intelligence quotient improvement were postoperative seizure freedom and preoperative low intelligence quotient. The percentage of seizure freedom in the tuberectomy group was significantly lower compared to the tuberectomy plus and lobectomy groups at 1- and 4-year follow-ups. In conclusion, this study, the largest nationwide multi-centre study on resective epilepsy surgery, resulted in improved seizure outcomes and quality of life and intelligence quotient improvements in patients with tuberous sclerosis complex. Seizure freedom was often achieved in patients with an outstanding tuber on MRI, total removal of epileptogenic tubers, and tuberectomy plus. Quality of life and intelligence quotient improvements were frequently observed in patients with postoperative seizure freedom and preoperative low intelligence quotient.
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  epilepsy surgery; multicentre study; quality of life; resective surgery; tuberous sclerosis complex

Mesh:

Year:  2020        PMID: 31953931     DOI: 10.1093/brain/awz411

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

Review 1.  Medical treatment of tuberous sclerosis-related epilepsy.

Authors:  Shimrit Uliel-Sibony; Veronika Chernuha; Hadas Meirson; Aviva Fattal-Valevski
Journal:  Childs Nerv Syst       Date:  2020-08-22       Impact factor: 1.475

Review 2.  Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.

Authors:  Rima Nabbout; Mathieu Kuchenbuch; Catherine Chiron; Paolo Curatolo
Journal:  CNS Drugs       Date:  2021-08-21       Impact factor: 5.749

3.  Interictal Discharge Pattern in Preschool-Aged Children With Tuberous Sclerosis Complex Before and After Resective Epilepsy Surgery.

Authors:  Liu Yuan; Yangshuo Wang; Shuhua Cheng; Junchen Zhang; Shaohui Zhang; Tinghong Liu; Guojun Zhang; Shuli Liang
Journal:  Front Neurol       Date:  2022-05-31       Impact factor: 4.086

4.  Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis Complex.

Authors:  Leslie E Grayson; Jurriaan M Peters; Tarrant McPherson; Darcy A Krueger; Mustafa Sahin; Joyce Y Wu; Hope A Northrup; Brenda Porter; Gary R Cutter; Sarah E O'Kelley; Jessica Krefting; Scellig S Stone; Joseph R Madsen; Aria Fallah; Jeffrey P Blount; Howard L Weiner; E Martina Bebin
Journal:  Pediatr Neurol       Date:  2020-04-14       Impact factor: 3.372

5.  Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18 F-FDG PET-CT values.

Authors:  Zhongke Wang; Kaixuan Huang; Xiaolin Yang; Kaifeng Shen; Ling Yang; Ruotong Ruan; Xianjun Shi; Miao Wang; Gang Zhu; Meihua Yang; Chunqing Zhang; Shengqing Lv; Hui Yang; Xiaotang Fan; Shiyong Liu
Journal:  Brain Pathol       Date:  2021-02-10       Impact factor: 6.508

Review 6.  Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine.

Authors:  Susanne Schubert-Bast; Adam Strzelczyk
Journal:  Ther Adv Neurol Disord       Date:  2021-07-17       Impact factor: 6.570

7.  Fast Ripples as a Biomarker of Epileptogenic Tuber in Tuberous Sclerosis Complex Patients Using Stereo-Electroencephalograph.

Authors:  Yangshuo Wang; Liu Yuan; Shaohui Zhang; Shuangshuang Liang; Xiaoman Yu; Tinghong Liu; Xiaofeng Yang; Shuli Liang
Journal:  Front Hum Neurosci       Date:  2021-06-16       Impact factor: 3.169

8.  Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from Germany.

Authors:  Johann Philipp Zöllner; Nadine Conradi; Matthias Sauter; Markus Knuf; Susanne Knake; Gerhard Kurlemann; Thomas Mayer; Christoph Hertzberg; Astrid Bertsche; Ilka Immisch; Karl Martin Klein; Klaus Marquard; Sascha Meyer; Anna H Noda; Felix von Podewils; Hannah Schäfer; Charlotte Thiels; Bianca Zukunft; Susanne Schubert-Bast; Janina Grau; Laurent M Willems; Felix Rosenow; Jens-Peter Reese; Adam Strzelczyk
Journal:  Neurol Res Pract       Date:  2021-06-28

9.  The Important Role of Perituberal Tissue in Epileptic Patients with Tuberous Sclerosis Complex by the Transcriptome Analysis.

Authors:  Shuqiang Li; Huijie Shao; Liansheng Chang
Journal:  Biomed Res Int       Date:  2020-10-15       Impact factor: 3.411

10.  Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex.

Authors:  Siu Hing Lo; Jade Marshall; Hanna Skrobanski; Andrew Lloyd
Journal:  Pharmacoecon Open       Date:  2021-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.